MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - pharmaceuticals
- TTK HEALTHCARE - MYLAN (US)
TTK HEALTHCARE vs MYLAN (US) - Comparison Results
MYLAN (US)
Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More
Financials
 TTK HEALTHCARE  MYLAN |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| TTK HEALTHCARE Mar-19 |
MYLAN Dec-18 |
TTK HEALTHCARE/ MYLAN |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 1,215 | 3,487 | - | |
| Low | Rs | 610 | 1,919 | - | |
| Sales per share (Unadj.) | Rs | 444.4 | 1,604.6 | - | |
| Earnings per share (Unadj.) | Rs | 17.2 | 43.6 | - | |
| Cash flow per share (Unadj.) | Rs | 27.6 | 344.0 | - | |
| Dividends per share (Unadj.) | Rs | 5.00 | 0 | - | |
| Dividend yield (eoy) | % | 0.5 | 0 | - | |
| Book value per share (Unadj.) | Rs | 177.9 | 1,735.9 | - | |
| Shares outstanding (eoy) | m | 14.13 | 514.50 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 2.1 | 1.7 | 121.9% | |
| Avg P/E ratio | x | 52.9 | 62.0 | 85.3% | |
| P/CF ratio (eoy) | x | 33.0 | 7.9 | 420.3% | |
| Price / Book Value ratio | x | 5.1 | 1.6 | 329.3% | |
| Dividend payout | % | 29.0 | 0 | - | |
| Avg Mkt Cap | Rs m | 12,894 | 1,390,845 | 0.9% | |
| No. of employees | `000 | 2.3 | 35.0 | 6.6% | |
| Total wages/salary | Rs m | 1,307 | 0 | - | |
| Avg. sales/employee | Rs Th | 2,715.7 | 23,587.6 | 11.5% | |
| Avg. wages/employee | Rs Th | 565.3 | 0 | - | |
| Avg. net profit/employee | Rs Th | 105.4 | 640.5 | 16.5% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 6,279 | 825,567 | 0.8% | |
| Other income | Rs m | 78 | 0 | - | |
| Total revenues | Rs m | 6,356 | 825,567 | 0.8% | |
| Gross profit | Rs m | 496 | 213,626 | 0.2% | |
| Depreciation | Rs m | 147 | 154,579 | 0.1% | |
| Interest | Rs m | 34 | 39,707 | 0.1% | |
| Profit before tax | Rs m | 393 | 19,341 | 2.0% | |
| Minority Interest | Rs m | 0 | 0 | - | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
| Tax | Rs m | 149 | -3,077 | -4.8% | |
| Profit after tax | Rs m | 244 | 22,418 | 1.1% | |
| Gross profit margin | % | 7.9 | 25.9 | 30.5% | |
| Effective tax rate | % | 37.9 | -15.9 | -238.4% | |
| Net profit margin | % | 3.9 | 2.7 | 142.9% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 2,717 | 460,996 | 0.6% | |
| Current liabilities | Rs m | 1,571 | 336,117 | 0.5% | |
| Net working cap to sales | % | 18.3 | 15.1 | 120.7% | |
| Current ratio | x | 1.7 | 1.4 | 126.1% | |
| Inventory Days | Days | 32 | 84 | 38.5% | |
| Debtors Days | Days | 47 | 93 | 50.0% | |
| Net fixed assets | Rs m | 991 | 160,146 | 0.6% | |
| Share capital | Rs m | 141 | 440 | 32.1% | |
| Net worth | Rs m | 2,514 | 893,113 | 0.3% | |
| Long term debt | Rs m | 3 | 963,955 | 0.0% | |
| Total assets | Rs m | 4,158 | 2,395,675 | 0.2% | |
| Interest coverage | x | 12.6 | 1.5 | 848.3% | |
| Debt to equity ratio | x | 0 | 1.1 | 0.1% | |
| Sales to assets ratio | x | 1.5 | 0.3 | 438.2% | |
| Return on assets | % | 6.7 | 2.6 | 257.4% | |
| Return on equity | % | 9.7 | 2.5 | 386.2% | |
| Return on capital | % | 16.9 | 3.2 | 532.6% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 173 | 171,553 | 0.1% | |
| From Investments | Rs m | 97 | -88,674 | -0.1% | |
| From Financial Activity | Rs m | -307 | -79,919 | 0.4% | |
| Net Cashflow | Rs m | -38 | 1,421 | -2.7% | |
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.26 Rs / USD
Compare TTK HEALTHCARE With: ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Compare TTK HEALTHCARE With: VENUS REMEDIES STRIDES PHARMA SCIENCE LUPIN SUN PHARMA ALKEM LABORATORIES
Today's Market
Indian Indices End Flat, GAIL and UPL Among Top Nifty Gainers(Closing)
Indian share markets continued their volatile trend during closing hours today and ended their day on a flat note.
Related Views On News
TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)
Feb 5, 2021 | Updated on Feb 5, 2021For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.
TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)
Jan 30, 2020 | Updated on Jan 30, 2020For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.
TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)
Jul 18, 2019 | Updated on Jul 18, 2019Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.
TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)
Mar 27, 2019 | Updated on Mar 27, 2019Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.
More Views on NewsMost Popular
It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)
Feb 24, 2021Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)
Feb 25, 2021In this video, I'll show you how to get started on the path to daily trading profits.
The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)
Feb 23, 2021An Indian company founded three decades ago in a garage caught my attention...
Gold 65,000 and Silver 84,000 in 2022
Feb 26, 2021In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.
More
